Navigation Links
CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCyte's Glycoprotein Products in Heart Attack Disease Model
Date:6/3/2008

BOTHELL, Wash., June 3 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (CellCyte) (OTC Bulletin Board: CCYG) has selected the Cardiovascular Phenotyping Core at Washington University School of Medicine in St. Louis to perform a study to further evaluate CellCyte's glycoprotein products. The goal of the study is to investigate the efficiency of CellCyte's glycoprotein products in a preclinical model of myocardial infarction (heart attack).

"We look forward to working with the scientific team at Washington University on this study, which will continue to advance the research and development efforts for our glycoprotein products," noted Ronald W. Berninger, Ph.D., Chief Scientific Officer at CellCyte. "These are highly experienced researchers, as demonstrated by the fact that they perform more than 6,000 surgical and imaging procedures annually. Outsourcing a portion of the preclinical work allows us to move our program forward more quickly and is complementary to our in-house scientific efforts," Berninger added.

About the Washington University School of Medicine

Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's Hospitals. The School of Medicine is one of the leading medical research, teaching, and patient care institutions in the nation, currently ranked third in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's Hospitals, the School of Medicine is linked to BJC HealthCare.

About CellCyte Genetics

CellCyte Genetics is a biotechnology company engaged in the discovery, development and commercialization of stem cell enabling therapeutic products. CellCyte is developing products to allow more efficient delivery and increased retention of adult stem cells to diseased organs, such as the heart. The goal of these therapies is to increase the number of stem ce
'/>"/>

SOURCE CellCyte Genetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate
2. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
3. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
4. Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy
5. deCODE Obesity Study Sheds Light on How Genetics Affects Risk and Onset of Common Diseases
6. ZymoGenetics Reports Positive Phase 1 Results for IL-21 With Nexavar(R)
7. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
8. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
9. Genetics Determine Optimal Drug Dose of Common Anticoagulant
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...BURGH, Nov. 24 ,, WHAT: Rom H... for 23 years following an auto accident, was actu...d was the subject of a Good Morning America segmen... to illustrate how people with Locked-in Syndrome ..., WHEN: Good Morning America -- Tuesday, Novemb...
(Date:11/24/2009)...ISON, N.J., Nov. 24 Ques...ld,s leading provider of diagnostic testing, infor...d to speak at the 21st Annual Piper Jaffray Health...n is scheduled for Wednesday, December 2, 2009 at ...e, the company will reaffirm its 2009 guidance for...
(Date:11/24/2009)...EGO, Nov. 24 Anadys Phar... that it will present at the 21st Annual Piper Jaf... 2009 at 9:00 a.m. EST (6:00 a.m. PST). The confe... Steve Worland, Ph.D., President and Chief Executi...Anadys and its clinical development programs, ANA5...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Amgen Named Presenting Sponsor of The Dempsey Challenge 3A A Journey For Hope 56650 1Amgen Named Presenting Sponsor of The Dempsey Challenge 3A A Journey For Hope 56650 2Amgen Named Presenting Sponsor of The Dempsey Challenge 3A A Journey For Hope 56650 3Amgen Named Presenting Sponsor of The Dempsey Challenge 3A A Journey For Hope 56650 4Ancient oceans offer new insight into the origins of animal life 9852 1Ancient oceans offer new insight into the origins of animal life 9852 249th ICAAC press kit now available online 9848 1
... Response or Reduction of,Lesion Size by More than...RNewswire-FirstCall/ - Nventa,Biopharmaceuticals C...itive results from a clinical trial examining the ...estigational therapeutic,vaccine for human papillo...highest grade of cervical dysplasia (CIN III). The...
...7 - Accentia,Biopharmaceuticals, Inc. (NASDAQ: ABP...of the American Academy of Allergy, Asthma, and,Im... CA. The,posters discussed findings from a survey ...the U.S., U.K., France, and Germany on the,burden ...udes of,the fungal etiology of CS, and the differe...
Other Medicine Technology:Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 2Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 3Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 4Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 5Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 6Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 2Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 3Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 4Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 5
(Date:11/27/2009)...27 The Gymboree Corporat... CFO/COO, will present at the NASDAQ OMX 23rd Inve...otel in London, England, on Wednesday, December 2,...e broadcast of The Gymboree Corporation,s presenta...ree.com, click on "Our Company" at the bottom of t...
(Date:11/27/2009)...ission vehicles may reduce future disease burden, ...lthDay News) -- Encouraging city dwellers to walk ... greater public health benefits than increased use...found. , The study compared the projected healt...ort scenarios for London, England, and Delhi, Indi...
(Date:11/27/2009)...alist manufacturers who use medical load cells at ... dollars by bringing in technology partner Flintec...f pro-active medical manufacturers are calling in ...their projects, ensuring that progress will not be...tially outdated technology. , ...
(Date:11/26/2009)...tetrathiomolybdate (TM) has been shown in studies ..., a disease caused by an overload of copper, and c...y little, however, is known about how the drug wor...Northwestern University researchers now has provid...ture of TM bound to copper-loaded metallochaperone...
(Date:11/26/2009)...rch Triangle Dental (RTDental), a leading dental g...ounced the expansion of its services to include LU...Macmillan. , Durham, N...o announce that Dr. Doug Macmillan, an experienced...onal advanced training seminar. RTDental’s ...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
... Plan of Action on Behalf of their Client, Joel, ...Services, Inc. and its ...ry,s law firm announced,today that they have filed...pose the misconduct and wrongdoings of,Durham Coun...
...EP MEDICATIONS , Insomnia occurs when people ha...t is a common sleep compliant. While a brief case ...itement or other emotion, more than 20 million Ame...nd often debilitating condition, can lead to sever...
... January 23, 2008RNA interference (RNAi) represent...olecules to silence specific genes associated with...s describing the state-of-the-art and potential th...a peer-reviewed journal published by Mary Ann Lieb...
...23 University students in America,are turning to ...whelming,numbers to boost their focus, stay up lat...scribed for Attention Deficit Hyperactivity Disord...,coveted drugs are no longer illegal, mind-alterin...
...uccess at European Patent Hearing is Confirmed by ...NBURGH, Scotland, January 23 The European Patent,...(the ,131, patent) not,valid as granted. In a ruli...ncing the EPO ruling as a success, despite the,fac...
...ow to Fight Premature Birth in Ohio, COLUMBUS, Oh... rate of premature birth is up once again from 12....erm births were recorded for,2005 and over 20 lawm...non-partisan caucus to increase awareness of,the s...
Other Medicine News:Health News:The Willie Gary Law Firm Files $1 Billion Lawsuit Against Durham County LME, Wake County LME, Five County LME, Mecklenberg County LME and Value Options, Inc. for Negligent and Intentional Misconduct Against Mental Health Agency 2Health News:AASM statement on use of sleep medications 2Health News:AASM statement on use of sleep medications 3Health News:The RNA drug revolution -- a new approach to gene therapy 2Health News:Prescription 'Mind Meds' Pose Dangerous Threat to College Students 2Health News:Aircraft Medical: European Patent Hearing 2Health News:Ohio Prematurity Caucus Forming to Meet Challenge 2Health News:Ohio Prematurity Caucus Forming to Meet Challenge 3
8.00mm Open Trephine Handle
Retinal Forceps: Smooth 1.0mm Tips, Vertical Action
Gass Retinal Detachment Hook, Flattened 13mm Fenestrated
Schockett Double Ended Depressor w/Clip
Medicine Products: